Leading Mercaptopurine , Supplier from INDIA to Washington, USA | City Drug Exporters
City Drug Exporters supplies Mercaptopurine , from INDIA to Washington, USA. Trusted pharmaceutical exporter for wholesalers, distributors, pharmacies, and healthcare procurement companies
Mercaptopurine is a purine antagonist and antimetabolite medication used primarily to treat acute lymphocytic leukemia (ALL) and severe autoimmune conditions. It is primarily manufactured and prescribed as a 50 mg tablet or oral suspension.
Mechanism of Action
Prodrug State: It is inactive in its parent form and requires cellular uptake.
Intracellular Conversion: Enzymes convert it into active metabolites, notably thioinosinic acid (TIMP) and thioguanine nucleotides (TGNs).
Synthesis Blockade: These metabolites inhibit de novo purine synthesis and become incorporated directly into DNA and RNA, causing cell death.
Cell Phase: The drug acts specifically in the S-phase of the cell cycle.
Pharmacokinetics
Absorption: Oral bioavailability is highly variable (averaging 5% to 50%) due to first-pass metabolism. Food, particularly dairy, decreases its absorption.
Distribution: It distributes widely into body water but enters the cerebrospinal fluid (CSF) negligibly. Plasma protein binding is approximately 19%.
Metabolism: It is inactivated primarily by two pathways: thiol methylation (via the TPMT enzyme) and oxidation (via xanthine oxidase).
Excretion: It is rapidly eliminated, with a plasma half-life of less than 2 hours. About 46% of a dose is excreted in the urine within 24 hours
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites:
https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
City Drug Exporters supplies Mercaptopurine , from INDIA to Washington, USA. Trusted pharmaceutical exporter for wholesalers, distributors, pharmacies, and healthcare procurement companies
Mercaptopurine is a purine antagonist and antimetabolite medication used primarily to treat acute lymphocytic leukemia (ALL) and severe autoimmune conditions. It is primarily manufactured and prescribed as a 50 mg tablet or oral suspension.
Mechanism of Action
Prodrug State: It is inactive in its parent form and requires cellular uptake.
Intracellular Conversion: Enzymes convert it into active metabolites, notably thioinosinic acid (TIMP) and thioguanine nucleotides (TGNs).
Synthesis Blockade: These metabolites inhibit de novo purine synthesis and become incorporated directly into DNA and RNA, causing cell death.
Cell Phase: The drug acts specifically in the S-phase of the cell cycle.
Pharmacokinetics
Absorption: Oral bioavailability is highly variable (averaging 5% to 50%) due to first-pass metabolism. Food, particularly dairy, decreases its absorption.
Distribution: It distributes widely into body water but enters the cerebrospinal fluid (CSF) negligibly. Plasma protein binding is approximately 19%.
Metabolism: It is inactivated primarily by two pathways: thiol methylation (via the TPMT enzyme) and oxidation (via xanthine oxidase).
Excretion: It is rapidly eliminated, with a plasma half-life of less than 2 hours. About 46% of a dose is excreted in the urine within 24 hours
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites:
https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 9975390171
Keywords
